Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
出版年份 2017 全文链接
标题
Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer
作者
关键词
Breast cancer, Estrogen-independent growth, Linc-RoR, ERK, DUSP7
出版物
Molecular Cancer
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-10-17
DOI
10.1186/s12943-017-0727-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
- (2016) N. A. Daurio et al. CANCER RESEARCH
- Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment
- (2016) Guowei Gu et al. CURRENT OPINION IN PHARMACOLOGY
- Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer
- (2016) Michael Robert Mancuso et al. CURRENT PROBLEMS IN CANCER
- Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells
- (2016) Wan-xin Peng et al. EXPERIMENTAL CELL RESEARCH
- LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56
- (2016) Abhinav K. Jain et al. MOLECULAR CELL
- Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
- (2016) Chihua Wu et al. MEDICAL SCIENCE MONITOR
- Regulatory Roles of MAPK Phosphatases in Cancer
- (2016) Heng Boon Low et al. Immune Network
- Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
- (2015) Ana Herrero et al. CANCER CELL
- Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
- (2015) Muralidharan Anbalagan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Linc-RoR promotes c-Myc expression through hnRNP I and AUF1
- (2015) Jianguo Huang et al. NUCLEIC ACIDS RESEARCH
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway
- (2014) Xiang-Song Wu et al. CANCER BIOLOGY & THERAPY
- SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
- (2014) Guoqiang Li et al. CANCER CELL
- lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
- (2014) Gabriel Eades et al. MOLECULAR CANCER RESEARCH
- MACROD2overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers
- (2014) Morassa Mohseni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocrine therapy: is the first generation of targeted drugs the last?
- (2013) K. I. Pritchard JOURNAL OF INTERNAL MEDICINE
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- (2013) Woong Y Hwang et al. NATURE BIOTECHNOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- LncRNA loc285194 is a p53-regulated tumor suppressor
- (2013) Qian Liu et al. NUCLEIC ACIDS RESEARCH
- ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
- (2013) Ana Rita Carlos et al. Nature Communications
- The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
- (2012) Ali Zhang et al. CELL RESEARCH
- Dual-specificity MAP kinase phosphatases (MKPs)
- (2012) Christopher J. Caunt et al. FEBS Journal
- High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
- (2012) C. Bartholomeusz et al. ONCOLOGIST
- Long noncoding RNAs and human disease
- (2011) Orly Wapinski et al. TRENDS IN CELL BIOLOGY
- Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
- (2010) Sabine Loewer et al. NATURE GENETICS
- MicroRNA-101-mediated Akt activation and estrogen-independent growth
- (2010) M Sachdeva et al. ONCOGENE
- EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer
- (2009) Yang Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Estrogen Receptor-α Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer
- (2009) Marleen Kok et al. JNCI-Journal of the National Cancer Institute
- Low phosphorylation of estrogen receptor (ER ) serine 118 and high phosphorylation of ER serine 167 improve survival in ER-positive breast cancer
- (2008) H. Yamashita et al. ENDOCRINE-RELATED CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started